Abstract

Schlafen-1 (Slfn-1), the prototypic member of the Schlafen family of proteins, was described as an inducer of growth arrest in T-lymphocytes and causes a cell cycle arrest in NIH3T3 fibroblasts prior to the G1/S transition. How Slfn-1 exerts its effects on the cell cycle is not currently known. We report that synchronized murine fibroblasts expressing Slfn-1 do not exit G1 when stimulated with fetal calf serum, platelet-derived growth factor BB (PDGF-BB) or epidermal growth factor (EGF). The induction of cyclin D1 by these stimuli was blocked in the presence of Slfn-1 as were all downstream cell cycle processes. Overexpression of cyclin D1 in growth-arrested, Slfn-1-expressing cells induced an increase in cell growth consistent with this protein being the biological target of Slfn-1. Activation of the mitogen-activated protein kinase pathway by EGF or phorbol 12-myristate 13-acetate was unaffected by Slfn-1 expression. PDGF signaling was, however, almost completely blocked. This was due to a lack of PDGF receptor expression in Slfn-1-expressing cells consistent with Slfn-1 blocking the cell cycle in G1 where PDGF receptor expression is normally down-regulated. Finally, overexpression of Slfn-1 inhibited the activation of the cyclin D1 promoter. Slfn-1 therefore causes a cell cycle arrest during G1 by inhibiting induction of cyclin D1 by mitogens.

Highlights

  • Schlafen-1 (Slfn-1)1 is a recently described protein, which has been shown to impair thymocyte development and causes a G1 arrest when expressed in fibroblasts [2]

  • We report that synchronized murine fibroblasts expressing Slfn-1 do not exit G1 when stimulated with fetal calf serum, platelet-derived growth factor BB (PDGF-BB) or epidermal growth factor (EGF)

  • We demonstrate that Slfn-1 inhibits the induction of cyclin D1 by fetal calf serum (FCS), epidermal growth factor (EGF), phorbol 12-myristate 13-acetate (PMA), and platelet-derived growth factor (PDGF)

Read more

Summary

The abbreviations used are

Slfn-1, Schlafen-1; LPS, lipopolysaccharide; SH-2, Src homology-2; MAP, mitogen-activated protein; CDK, cyclin-dependent kinases; FCS, fetal calf serum; EGF, epidermal growth factor; EGFP, enhanced green fluorescent protein; PMA, phorbol 12-myristate 13-acetate; PDGF, platelet-derived growth factor; MEK-1, MAP/ERK kinase-1; PBS, phosphate-buffered saline; Tricine, N-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]glycine; RT, reverse transcription; CHO, Chinese hamster ovary. Entry of quiescent cells into the cell cycle is triggered experimentally by growth factors, many of which act via receptor tyrosine kinases [11] In these systems, binding of a growth factor to its cognate receptor induces trans-phosphorylation on adjacent intracellular receptor chains [12], facilitating Src homology-2 (SH-2) domain protein interactions and activation of downstream pathways, such as the Ras/mitogen-activated protein (MAP) kinase pathway [13, 14] and PI3 kinase/Akt pathways [15,16,17]. Our study identifies mitogen-driven cyclin D1 induction as a target of Slfn-1 in its ability to cause a mid-G1 arrest in the cell cycle

EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call